Humanity and Health Research Centre
Quick facts
Marketed products
- SOF+DCV · Other
- SOF+PEG+RBV · Other
- SOF+RBV · Virology / Hepatology
SOF+RBV is a combination of sofosbuvir (a nucleotide polymerase inhibitor) and ribavirin (a nucleoside analog) that inhibits hepatitis C virus replication. - Tenofovir alafenamide(TAF) · Infectious Disease / Virology
Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor that blocks HIV reverse transcriptase, preventing viral replication.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: